Showing results (61-70 of 250) with videos related to
Sort By:
Pageof 25
Oncogene|September 21, 2004
HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradationPaola Massimi, Noor Gammoh, Miranda Thomas, et al.Expert Opinion on Biological Therapy|March 21, 2008
Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacyEyad Elkord, Robert E Hawkins, Peter L SternOncogene|September 13, 2003
Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300Agnieszka Bernat, Nikita Avvakumov, Joe S Mymryk, et al.Virology|February 8, 2014
The human papillomavirus (HPV) E6 oncoproteins promotes nuclear localization of active caspase 8Joaquin Manzo-Merino, Paola Massimi, Marcela Lizano, et al.Journal of Cell Science|November 20, 2003
Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytesRichard A Watson, Miranda Thomas, Lawrence Banks, et al.International Journal of Cancer|March 7, 2012
Regulation of the DLG tumor suppressor by β-cateninVanitha Krishna Subbaiah, Nisha Narayan, Paola Massimi, et al.Journal of Virology|January 28, 2006
Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activatorNoor Gammoh, Helena Sterlinko Grm, Paola Massimi, et al.Virology|July 11, 2014
Human papillomavirus infection requires the TSG101 component of the ESCRT machineryJustyna Broniarczyk, Martina Bergant, Anna Goździcka-Józefiak, et al.Journal of Virology|January 19, 2022
Loss of the E6AP Ubiquitin Ligase Induces p53-Dependent Phosphorylation of Human Papillomavirus 18 E6 in Cells Derived from Cervical CancerArushi Vats, Neva Skrabar, Giannino Del Sal, et al.Oncogene|April 28, 2005
Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoproteinHelena Sterlinko Grm, Paola Massimi, Noor Gammoh, et al.Pageof 25